LGD-3303
Price on application
LGD-3303 is an orally bioavailable, non-steroidal SARM developed by Ligand Pharmaceuticals. It demonstrates potent and full agonist activity on muscle and bone androgen receptors while maintaining tissue selectivity over reproductive organs.
Research Profile
LGD-3303 is considered one of the most potent SARMs in terms of its anabolic-to-androgenic ratio. Preclinical studies in animal models have shown significant increases in muscle mass and bone mineral density at relatively low doses. Unlike partial agonists, LGD-3303 acts as a full agonist in target tissues, which may translate to more robust anabolic effects. Its oral bioavailability and favorable pharmacokinetic profile make it a practical compound for research settings investigating muscle wasting, osteoporosis, and body composition.
Technical Details
- Chemical Formula
- C16H14ClF3N2O
- Synonyms
- LGD-3303
- Molecular Weight
- 342.74 g/mol
- CAS Number
- 917891-35-1
- Active Ingredient
- 350mg (10mg per capsule)
- Shelf Life
- 36 months